Article
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) - 1 Aug 2019
Petersen Eva Rosa, Søndergaard Helle Bach, Laursen Julie Hejgaard, Olsson Anna Gabriella, Börnsen Lars, Soelberg Sørensen Per, Sellebjerg Finn, Bang Oturai Annette
Abstract excerpt
BACKGROUND: Smoking has been associated with increased multiple sclerosis (MS) risk, disease worsening, and progression in MS patients. Furthermore, interactions between smoking and human leukocyte antigen (HLA) genes have been shown for MS risk. Recently, we found that smoking was associated with an increased relapse rate in interferon-beta-treated relapsing-remitting multiple sclerosis (RRMS) patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.